Profound Medical
PROF
33 hedge funds and large institutions have $98.7M invested in Profound Medical in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 12 increasing their positions, 11 reducing their positions, and 2 closing their positions.
145% more call options, than puts
Call options by funds: $267K | Put options by funds: $109K
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
38% more capital invested
Capital invested by funds: $71.7M → $98.7M (+$27M)
3% more funds holding
Funds holding: 32 → 33 (+1)
9% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 11
0.85% less ownership
Funds ownership: 37.01% → 36.15% (-0.85%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$850K |
| 2 |
GA
Gagnon Advisors
New York
|
+$382K |
| 3 |
Goldman Sachs
New York
|
+$207K |
| 4 |
Fidelity International
Hamilton,
Bermuda
|
+$161K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$151K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GS
Gagnon Securities
New York
|
-$1.43M |
| 2 |
ZDA
Zweig-DiMenna Associates
New York
|
-$1.07M |
| 3 |
TIM
Timelo Investment Management
Aurora,
Ontario, Canada
|
-$304K |
| 4 |
Jane Street
New York
|
-$162K |
| 5 |
RA
Royce & Associates
New York
|
-$63.3K |
PROF Hedge Fund Activity: Q2 2023 in Review
33 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Profound Medical (PROF) for Q2 2023, worth a combined $98.7M — up 38% from $71.7M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new PROF positions and 2 closed out — a net gain of 1 holder — while 12 added to existing stakes and 11 trimmed.
The largest buyer was Raymond James Financial Services Advisors, adding an estimated $850K. The largest seller was Gagnon Securities, cutting an estimated $1.43M.
- 33 institutional investors held Profound Medical (PROF) as of Q2 2023, up from 32 in Q1 2023.
- Funds reported $98.7M of Profound Medical stock for Q2 2023, up 38% quarter-over-quarter.
- 3 funds opened new Profound Medical positions in Q2 2023 and 2 closed out, a net change of +1 holder.
- The largest Profound Medical buyer in Q2 2023 was Raymond James Financial Services Advisors, an estimated $850K added.
- The largest Profound Medical seller in Q2 2023 was Gagnon Securities, an estimated $1.43M sold.
Based on aggregated 13F filings for Q2 2023.